RECENT NEWS

Faecal immunochemical testing: the clear path to an effective, efficient service

Faecal immunochemical testing: the clear path to an effective, efficient service

Approximately 41,000 people are diagnosed with colorectal cancer (CRC) in the UK each year, and over 90% of cases are treated successfully following early detection. Diagnosis of CRC is normally achieved by colonoscopy; however, UK endoscopy resources are stretched to breaking point.
Major Northern Ireland tender won by UK IVD diagnostics manufacturer

Major Northern Ireland tender won by UK IVD diagnostics manufacturer

Medical diagnostics manufacturer Helena Biosciences, working in collaboration with AB Scientific, has been awarded the Northern Ireland regional tender for the supply and delivery of clinical electrophoresis. Helena Biosciences is a manufacturer of medical diagnostics equipment used in clinical laboratories worldwide.
Portable fingerprint drug testing in the Antipodes

Portable fingerprint drug testing in the Antipodes

Melbourne-based Henley Health has been appointed as Intelligent Fingerprinting’s first Asia Pacific region distributor for its new non-invasive and flexible drug test solution. The world’s first portable fingerprint-based drug test – which works by analysing sweat from a fingerprint to determine if someone has recently used cocaine, opiates, amphetamines or cannabis – is now available in Australia and New Zealand following this agreement.
First-time exhibitor at Analytica

First-time exhibitor at Analytica

Autoscribe Informatics will be exhibiting for the first time at Analytica 2018.This will provide visitors with the chance to see the versatile and powerful Matrix Gemini laboratory I information management system (LIMS), which is supported through a network of distributors across mainland Europe. Characterised by its easy-to-use graphical configuration tools, and with a dual desktop/web interface included as standard, Matrix can be used to create LIMS solutions that meet the exact needs of customers.
Earlier clinical decision-making in emergency paediatrics: the role of POCT

Earlier clinical decision-making in emergency paediatrics: the role of POCT

A study recently undertaken and published by the Oxford Academic Health Science Network (AHSN) has shown that Horiba’s Microsemi CRP point-of-care testing (POCT) analyser facilitates more rapid clinical decision-making, saving time and reducing costs, in emergency paediatric units. The study found that using POCT as a replacement for laboratory tests resulted in earlier decision-making in approximately 75% of cases across three hospital sites. Economic analysis across these sites found that this could result in net annual cost savings due to reduced staff time, as well as faster decisions on antibiotic use.
Enhanced patient outcomes at Leicester emergency department

Enhanced patient outcomes at Leicester emergency department

Radiometer has implemented its AQURE Enterprise point-of-care (POC) data management system at the University of Leicester Hospitals NHS Trust’s new emergency department (ED). Radiometer has also provided support in configuring the interface of the trust’s Sunquest Integrated Clinical Environment (ICE) EPR system so that blood gas test results are automatically linked to an individual’s electronic patient record (EPR).
Rapid Diagnostics – Time is Relative: a BSMT conference

Rapid Diagnostics – Time is Relative: a BSMT conference

The British Society for Microbial Technology (BSMT) is offering an excellent programme for its annual scientific conference, to be held on Friday, 18 May 2018 in London. This year, the focus of the meeting will be on Rapid Diagnostics – Time is Relative. While aimed at bench microbiologists, the conference is relevant for senior biomedical and clinical scientists, other scientists and medical microbiologists.
New blood test for breast cancer patients

New blood test for breast cancer patients

A new study has found that a blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests. Scientists from The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, say the test could detect in two to three weeks whether or not the drug is working, although they caution that the results need replicating before they are used clinically.
In-depth guide to prepared culture media

In-depth guide to prepared culture media

Cherwell Laboratories has published an eBook entitled The Pharmaceutical and Cleanroom Industry’s Pocket Guide to Prepared Culture Media. Available to download from the company’s website, the new guide is intended for anyone involved in using and/or buying microbiological media. It aims to provide an understanding of the best practices and breadth of prepared culture media options for various applications.
Point-of-care CRP testing reduces unnecessary admissions

Point-of-care CRP testing reduces unnecessary admissions

Horiba UK Medical has announced that Thame and Marlow Community Hubs, within Buckinghamshire Healthcare NHS Trust, have each installed the company’s latest point-of-care testing (POCT) analyser, the Microsemi CRP. These new analysers are now streamlining existing diagnostic pathways in the community and helping to reduce local accident and emergency (A&E) admissions for frail patients.
Development of immunohistochemistry assays for oncology

Development of immunohistochemistry assays for oncology

Horizon Discovery Group has entered into an agreement with Roche Diagnostics to assist in the development of immunohistochemistry (IHC) assays. Under the terms of the agreement, Horizon will develop and provide reference standard material expressing neurotrophic tropomyosin receptor kinase (NTRK) fusion biomarkers.
Diagnosing immunity to Ebola

Diagnosing immunity to Ebola

A new approach to the detection of immunity to Ebola virus infection has been developed by researchers in a collaboration between University College London (UCL) and Imperial College London. Published in ACS Nano, the new approach uses lateral-flow technology, coupled with smartphones to provide a promising alternative to laboratory-based testing.
Diphtheria: forgotten but definitely not gone away

Diphtheria: forgotten but definitely not gone away

Caused by the bacterium Corynebacterium diphtheriae, diphtheria is an infection the signs and symptoms of which may vary from mild to severe. They usually start two to five days after exposure. Symptoms often come on fairly gradually, beginning with a sore throat and fever. Although popularly considered a disease of the past, widespread infection in South East Asia has brought the condition in sharp focus, as did a poster on the subject displayed at the IBMS Biomedical Science Congress last year.
Influenza: a century on

Influenza: a century on

This year is the 100th anniversary of the outbreak of the 1918 influenza pandemic (also known as Spanish flu). It was an unusually deadly influenza pandemic, the first of the two pandemics involving the H1N1 influenza virus. It infected 500 million people around the world, including remote Pacific islands and the Arctic, and resulted in the deaths of 50–100 million people, making it one of the deadliest natural disasters in human history.
Expression of uncertainty in measurement

Expression of uncertainty in measurement

The fifth in the series of articles on individual aspects of the assessment of uncertainty of measurement is scheduled for publication in the February issue of Pathology in Practice, and will see Stephen MacDonald consider some of the more difficult questions that may be faced in relation to measurement uncertainty
Initiative to raise awareness of HPV diseases in men welcomed

Initiative to raise awareness of HPV diseases in men welcomed

The Royal Society for Public Health (RSPH) has welcomed the launch of Jabs for the Boys, an initiative that aims to increase awareness of diseases in men caused by the human papillomavirus (HPV). This virus causes thousands of cases of cancer in men every year in the UK, such as p16-positive, HPV-associated squamous cell carcinoma (pictured), but there is very little public awareness of the virus, especially in relation to men.
UK and Russian researchers join forces against AMR

UK and Russian researchers join forces against AMR

Two of the key organisations in the UK and Russia leading efforts to combat the global problem of antimicrobial resistance (AMR) have announced a formal agreement to work together. The AMR Centre (AMRC), located at Alderley Park, Cheshire, is to collaborate with Russian science and technology organisation, the Skolkovo Foundation, which is based in Moscow. They will work in partnership to identify opportunities for joint UK-Russian funding to support collaborative projects between organisations in both countries.
Centralising quality and corrective action management

Centralising quality and corrective action management

Labcold, the UK medical refrigeration organisation, is working with Ideagen to centralise its quality management systems in order to solidify corrective action management and customer feedback. The Basingstoke-based company, which was the first blood bank refrigeration manufacturer in the UK to gain a medical device certification, is to implement Ideagen’s Q-Pulse software across its UK operations.
Ebola virus monoclonal antibodies

Ebola virus monoclonal antibodies

Ebola virus causes severe haemorrhagic fever with a high fatality rate. Human-to-human transmission is through contact with body fluids, and recent well-documented outbreaks occurred during 2013–2015 in West Africa. The natural reservoir of this RNA virus is thought to be bats, and several strains of the virus have emerged, including the Zaire, Sudan and Bundi variants.
Investment aims to improve infection prevention

Investment aims to improve infection prevention

A University of Manchester spin-out behind a medical device designed to detect life-threatening infections will begin its first clinical trial following a £1.4 million investment boost. Through its iPad mini-sized device, MicroBioSensor aims to help people with kidney failure undergoing peritoneal dialysis.

Upcoming Events

Update Course in Gynaecological Cytology

London Regional Cytology Training Centre, Level 6X, St Marks Building, Watford Road, Harrow HA1 3UJ
12-14 December 2018

Managing Cultural Differences in the Workplace

The Holiday Inn - Kensington Forum, 97 Cromwell Road, London SW7 4DN
21 January 2019

British Society for Haematology Paediatric Symposium

Royal College of Paediatrics and Child Health, 5-11 Theobalds Road, London WC1X 8SH
14 February 2019

Challenges in the clinical biochemistry laboratory and beyond

The Royal College of Pathologists
28 February 2019

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Dec 2018

Molecular diagnostics and LAMP technology

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.